Company Description
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies.
The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products.
In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.
Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.
Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions.
The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
| Country | United States |
| Founded | 1979 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 48,900 |
| CEO | Jason Hollar |
Contact Details
Address: 7000 Cardinal Place Dublin, Ohio 43017 United States | |
| Phone | 614 757 5000 |
| Website | cardinalhealth.com |
Stock Details
| Ticker Symbol | CAH |
| Exchange | NYSE |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000721371 |
| CUSIP Number | 14149Y108 |
| ISIN Number | US14149Y1082 |
| Employer ID | 31-0958666 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical and Specialty Solutions Segment |
| Stephen M. Mason | Chief Executive Officer of Medical Segment |
| Jason M. Hollar | Chief Executive Officer and Director |
| Aaron E. Alt | Chief Financial Officer |
| Jessica L. Mayer | Chief Legal and Compliance Officer |
| Mary C. Scherer | Senior Vice President and Chief Accounting Officer |
| Michelle D. Greene | Executive Vice President, Chief Information Officer and Customer Support Services |
| Matt Sims | Vice President of Investor Relations |
| Ola M. Snow | Chief Human Resources Officer |
| Craig Cowman | Executive Vice President of Biopharma Solutions and Strategic Sourcing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 1, 2024 | 10-Q | Quarterly Report |
| Nov 1, 2024 | 8-K | Current Report |
| Oct 24, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 23, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 10, 2024 | 8-K | Current Report |
| Oct 2, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Sep 16, 2024 | ARS | Filing |
| Sep 16, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Sep 16, 2024 | DEF 14A | Other definitive proxy statements |
| Sep 9, 2024 | 8-K | Current Report |